Cytospire Therapeutics

News

Cytospire was in the spotlight this morning after announcing an oversubscribed Series A to fund a new form of T-cell engager (TCE) for cancer.

News

Germany's government is reportedly scrapping plans to introduce a controversial system of variable rebates on medicines.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.